T1 Level 373 394 drug-resistant cells3
T2 Organism 63 71 patients
T3 Level 1278 1282 cell
T4 Condition 1287 1310 acute myeloid leukaemia
T5 Level 666 670 cell
T6 Condition 177 186 mutations
T7 Condition 1100 1124 leukaemia stem cell gene
T8 Level 1629 1649 leukaemia stem cells
T9 Intervention 569 576 genetic
T10 Condition 3 26 acute myeloid leukaemia
T11 Condition 457 488 acute myeloid leukaemia samples
T12 Level 2117 2125 cellular
T13 Level 929 933 cell
T14 Condition 457 480 acute myeloid leukaemia
T15 Condition 2001 2024 acute myeloid leukaemia
T16 Biomarker 373 377 drug
T17 Level 388 392 cell
T18 Level 1515 1519 cell
T20 Level 1813 1817 cell
T21 Intervention 829 838 leukaemic
T22 Biomarker 295 299 drug
T23 Level 1644 1648 cell
T24 Level 1772 1818 immunophenotypically committed leukaemia cells
T25 Level 656 671 resistant cells
T26 Level 378 393 resistant cells
T27 Level 1497 1520 therapy-resistant cells
T28 Biomarker 295 301 drugs2
T29 Intervention 1759 1768 subclones
T30 Intervention 1372 1379 genetic
T31 Level 982 1006 leukaemia stem cells9,10
T32 Protein 1076 1094 properties11,12,13
T33 Gene 1235 1247 correlative7
T34 Intervention 1840 1848 stemness
T35 Intervention 569 586 genetic subclones
T36 Intervention 2078 2086 stemness
T37 Intervention 750 762 therapy6,7,8
T38 Intervention 2223 2231 stemness
T39 Level 982 1002 leukaemia stem cells
T40 Level 1677 1702 progenitor cell phenotype
T41 Level 1263 1283 leukaemia stem cells
T42 Level 1688 1692 cell
T43 Level 1416 1467 subpopulations and xenografts from paired diagnosis
T44 Protein 1180 1192 failure14,15
T45 Level 1657 1676 haematopoietic stem
T46 Level 997 1001 cell
T48 Level 2117 2121 cell
T49 Level 1115 1119 cell
T50 Level 1468 1483 relapse samples
T51 Biomarker 200 204 drug
R1 Relation Arg1:T51 Arg2:T22
